Cargando…
Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain
OBJECTIVE: Protection against vaccine-preventable diseases is especially relevant in older adults due to age-related decline in immunity (immunosenescence). However, adult vaccination remains a challenge with overall low coverage rates, which has an impact on both the patients who have these disease...
Autores principales: | Gil de Miguel, Ángel, Eiros Bouza, José María, Martínez Alcorta, Luis Ignacio, Callejo, Daniel, Miñarro, Carlos, Vallejo-Aparicio, Laura Amanda, García, Andrea, Tafalla, Mónica, Cambronero, María del Rosario, Rodríguez, Rubén, Martin-Gomez, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899779/ https://www.ncbi.nlm.nih.gov/pubmed/35254649 http://dx.doi.org/10.1007/s41669-022-00329-3 |
Ejemplares similares
-
Cost–consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma
por: Vallejo-Aparicio, Laura Amanda, et al.
Publicado: (2019) -
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
por: Paly, Victoria Federico, et al.
Publicado: (2022) -
Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS
por: Vallejo-Aparicio, Laura Amanda, et al.
Publicado: (2018) -
Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain
por: Tafalla, Monica, et al.
Publicado: (2010) -
Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain
por: Moreno, Santiago, et al.
Publicado: (2023)